Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention
about
Gene Therapy for Cardiovascular DiseaseTreatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Hirudin Protects Ang II-Induced Myocardial Fibroblasts Fibrosis by Inhibiting the Extracellular Signal-Regulated Kinase1/2 (ERK1/2) Pathway
P2860
Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention
description
im Januar 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 2002
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2002
@uk
name
Efficacy of hirudin in reducin ...... utaneous coronary intervention
@en
Efficacy of hirudin in reducin ...... utaneous coronary intervention
@nl
type
label
Efficacy of hirudin in reducin ...... utaneous coronary intervention
@en
Efficacy of hirudin in reducin ...... utaneous coronary intervention
@nl
prefLabel
Efficacy of hirudin in reducin ...... utaneous coronary intervention
@en
Efficacy of hirudin in reducin ...... utaneous coronary intervention
@nl
P2093
P356
P1476
Efficacy of hirudin in reducin ...... utaneous coronary intervention
@en
P2093
Natarajan MK
Rupprecht HJ
P304
P356
10.1053/EUHJ.2001.2731
P577
2002-01-01T00:00:00Z